Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
View Older Stories View More Recent Stories
-
Eurand Completes Public Offering, Including Exercise of the Underwriters' Over-Allotment Option, for Total Net Proceeds of Approximately $103.9 Million
-
GSI Commerce to Acquire Retail Convergence and Enter Private Sale Space with Addition of Rue La La
-
Delcath Systems (DCTH) Announces 8.5M Common Stock Offering
-
Delcath Systems, Inc. Announces Public Offering of Common Stock
-
Cowen & Co Initiates Coverage on Qiagen (QGEN) with an Outperform
-
Laterooms and Octopus Travel Top Greenlight's Integrated Search Report For the Hotel Sector
-
Company Profile for The Cowen Group
-
Cowen & Co Initiates Coverage on Natural and Organic Foods Stocks
-
Morning Movers 10/22: HTE, SDXC, SXI, NYT, FFIV, SKX, JCG Higher; TQNT, WSTL, NWK, EPAX, AFFX, NCR Lower
-
Cowen & Co Upgrades J. Crew Group (JCG) to Neutral
-
Eurand Announces Pricing of Offering of Ordinary Shares
-
China BAK to Raise $20.6 Million in Registered Direct Offering
-
Pharmos Corporation Engages Cowen to Assist the Company with Accelerating a Partnership for Dextofisopam
-
Notable Analyst Rating Changes 10/21: CAT, CSCO, SYK, FRX Upgraded; LMT, EAT, NVS Downgraded
-
Cowen & Co Upgrades Forest Laboratories (FRX) to Outperform
-
Cowen Group Q3 Staffing Report Released
-
Amarin Announces Completion of $70 Million Private Placement
-
Eurand Announces Proposed Public Offering of Ordinary Shares
-
Two Independent Surveys Find Clearwell Systems the Leader in Early Case Assessment
-
Dyax Announces New Developments Related to Phage Display-Discovered Drug Candidates
-
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
-
Cowen Downgrades Onyx Pharma (ONXX) to Market Perform
-
Notable Analyst Rating Changes 10/12: BNI, MA, V, BBW, AMD, KR, PCG Upgrade; SNDK, OXY, NOK, LMT, BIDU Downgrade
-
David Moenning's Daily State of the Markets: Subtle, Yet Effective
-
Cowen & Co Downgrades Lockheed Martin (LMT) to Neutral
-
Cowen & Co Downgrades AstraZeneca (AZN) to Neutral
-
Notable Analyst Rating Changes 10/9: VIA, AKS, SY, MAR, RIMM; ARO, MT, BMY, LTD Downgrade
-
Cowen & Co Downgrades Bristol-Myers (BMY) to Neutral
-
David Moenning's Daily State of the Markets: A Day In The Life
-
Cowen & Co Upgrades Novartis (NVS) to Outperform
-
Cowen & Co Upgrades American Eagle Outfitters (AEO) to Neutral
-
Keefe, Bruyette & Woods Maintains an 'Outperform' on Cowen & Company (COWN); Adjusts Estimates & PT
-
Wilson Quarterly: Is Print Dead?
-
PlacementTracker Publishes PIPE Market League Tables
-
Moog (MOG) Announces Closing of Sale of 2,675,000 Shares At $29.50 A Share
-
Moog Inc. Announces Closing of Sale of 2,675,000 Shares of Class A Common Stock
-
Navigation Capital Partners Recapitalizes Five Star Food Service
-
Moog Inc. (MOG.A) Prices 2.5M Shares At $29.50 A Share
-
Moog Inc. Announces Pricing for Class A Common Stock Offering
-
Moog Inc. Announces Offering of Class A Common Stock
-
TD AMERITRADE Names David Kimm Chief Risk Officer
-
Newegg Files $175M IPO
-
Notable Analyst Rating Changes 9/25: UAUA, APA, AXP, CAT, FMCN, COL Upgraded; RIMM, ABV, EMCI, MNKD, TXT Downgraded
-
Cowen & Co Downgrades Textron (TXT) to Neutral
-
Cowen & Co Initiates Coverage on Dollar Tree (DLTR) with a Neutral
-
Cowen & Co Upgrades DealerTrack (TRAK) to Outperform
-
Cowen & Co Downgrades Abercrombie (ANF) to Underperform
-
David Moenning's Daily State of the Markets: Need I Say More?
-
Cowen & Co Upgrades Natus Medical (BABY) to Outperform
-
David Moenning's Daily State of the Markets: Keep An Ear To The Ground
